Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Creager

Showing results (51-60 of 292) with videos related to

Pageof 30
Sort By:
Vascular Medicine (London, England)|March 12, 2021
SVM Communications: Interview with writing committee of Advanced Training Statement on vascular medicine and talking points from Paclitaxel CoalitionDaniella Kadian-Dodov, Mark A Creager, Naomi M Hamburg, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|September 24, 2010
Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery diseaseWilliam R Hiatt, Mark A Creager, Antonino Amato, et al.
Vascular Medicine (London, England)|January 30, 2003
The contribution of nitric oxide to exercise hyperemia in the human forearmMary Beth Gordon, Rajiv Jain, Joshua A Beckman, et al.
Circulation|September 25, 2003
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part IMark A Creager, Thomas F Lüscher, Francesco Cosentino, et al.
Circulation|August 9, 2006
Advanced glycation end products: sparking the development of diabetic vascular injuryAlison Goldin, Joshua A Beckman, Ann Marie Schmidt, et al.
Angiology|May 25, 2004
Special communication: mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular healthAlan T Hirsch, Peter Gloviczki, Alain Drooz, et al.
Diabetes Care|April 24, 2014
Response to comment on Goldfine et al. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes care 2013;36:4132-4139Allison B Goldfine, Kathleen A Jablonski, Steven E Shoelson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 3, 2007
Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004Todd S Perlstein, Reena L Pande, Joshua A Beckman, et al.
Journal of Cardiac Failure|September 30, 2009
Central aortic stiffness is increased in patients with heart failure and preserved ejection fractionAkshay S Desai, Gary F Mitchell, James C Fang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 22, 2016
Ebselen does not improve oxidative stress and vascular function in patients with diabetes: a randomized, crossover trialJoshua A Beckman, Allison B Goldfine, Jane A Leopold, et al.
Pageof 30

Showing results (51-60 of 292) with videos related to

Sort By:
Pageof 30
Vascular Medicine (London, England)|March 12, 2021
SVM Communications: Interview with writing committee of Advanced Training Statement on vascular medicine and talking points from Paclitaxel CoalitionDaniella Kadian-Dodov, Mark A Creager, Naomi M Hamburg, et al.
Journal of Cardiopulmonary Rehabilitation and Prevention|September 24, 2010
Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery diseaseWilliam R Hiatt, Mark A Creager, Antonino Amato, et al.
Vascular Medicine (London, England)|January 30, 2003
The contribution of nitric oxide to exercise hyperemia in the human forearmMary Beth Gordon, Rajiv Jain, Joshua A Beckman, et al.
Circulation|September 25, 2003
Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part IMark A Creager, Thomas F Lüscher, Francesco Cosentino, et al.
Circulation|August 9, 2006
Advanced glycation end products: sparking the development of diabetic vascular injuryAlison Goldin, Joshua A Beckman, Ann Marie Schmidt, et al.
Angiology|May 25, 2004
Special communication: mandate for creation of a national peripheral arterial disease public awareness program: an opportunity to improve cardiovascular healthAlan T Hirsch, Peter Gloviczki, Alain Drooz, et al.
Diabetes Care|April 24, 2014
Response to comment on Goldfine et al. Targeting inflammation using salsalate in patients with type 2 diabetes: effects on flow-mediated dilation (TINSAL-FMD). Diabetes care 2013;36:4132-4139Allison B Goldfine, Kathleen A Jablonski, Steven E Shoelson, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 3, 2007
Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004Todd S Perlstein, Reena L Pande, Joshua A Beckman, et al.
Journal of Cardiac Failure|September 30, 2009
Central aortic stiffness is increased in patients with heart failure and preserved ejection fractionAkshay S Desai, Gary F Mitchell, James C Fang, et al.
American Journal of Physiology. Heart and Circulatory Physiology|October 22, 2016
Ebselen does not improve oxidative stress and vascular function in patients with diabetes: a randomized, crossover trialJoshua A Beckman, Allison B Goldfine, Jane A Leopold, et al.
Pageof 30